Who Paid My Doc
Chantix
Drug Neuroscience;Tobacco Dependence
NDC 0069-0471-03
General payments
$937,663
Research payments
$471,206
Through program year 2024, $937,663 in general payments and $471,206 in research payments were reported against Chantix (Neuroscience;Tobacco Dependence).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $33 | 2 |
| 2023 | Research | $6,580 | 7 |
| 2022 | Research | $1,860 | 3 |
| 2021 | General | $23,135 | 437 |
| 2021 | Research | $179,469 | 11 |
| 2020 | General | $913,321 | 59,931 |
| 2020 | Research | $283,297 | 27 |
| 2019 | General | $1,174 | 103 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
60,473 general · 48 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.